<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Jin B</submitter><funding>NCI NIH HHS</funding><pagination>14356-65</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC2863211</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>285(19)</volume><pubmed_abstract>Nuclear factor-kappaB (NF-kappaB)-based signaling regulates diverse biological processes, and its deregulation is associated with various disorders including autoimmune diseases and cancer. Identification of novel factors that modulate NF-kappaB function is therefore of significant importance. The Mastermind-like 1 (MAML1) transcriptional co-activator regulates transcriptional activity in the Notch pathway and is emerging as a co-activator of other pathways. In this study, we found that MAML1 regulates NF-kappaB signaling via two mechanisms. First, MAML1 co-activates the NF-kappaB subunit RelA (p65) in NF-kappaB-dependent transcription. Second, MAML1 causes degradation of the inhibitor of NF-kappaB (IkappaBalpha). Maml1-deficient mouse embryonic fibroblasts showed impaired tumor necrosis f</pubmed_abstract><journal>The Journal of biological chemistry</journal><pubmed_title>The mastermind-like 1 (MAML1) co-activator regulates constitutive NF-kappaB signaling and cell survival.</pubmed_title><pmcid>PMC2863211</pmcid><funding_grant_id>R01 CA036167</funding_grant_id><funding_grant_id>R01 CA097148</funding_grant_id><pubmed_authors>Griffin JD</pubmed_authors><pubmed_authors>Wu L</pubmed_authors><pubmed_authors>Lin S</pubmed_authors><pubmed_authors>Jin B</pubmed_authors><pubmed_authors>Chen Z</pubmed_authors><pubmed_authors>Li JL</pubmed_authors><pubmed_authors>Shen H</pubmed_authors></additional><is_claimable>false</is_claimable><name>The mastermind-like 1 (MAML1) co-activator regulates constitutive NF-kappaB signaling and cell survival.</name><description>Nuclear factor-kappaB (NF-kappaB)-based signaling regulates diverse biological processes, and its deregulation is associated with various disorders including autoimmune diseases and cancer. Identification of novel factors that modulate NF-kappaB function is therefore of significant importance. The Mastermind-like 1 (MAML1) transcriptional co-activator regulates transcriptional activity in the Notch pathway and is emerging as a co-activator of other pathways. In this study, we found that MAML1 regulates NF-kappaB signaling via two mechanisms. First, MAML1 co-activates the NF-kappaB subunit RelA (p65) in NF-kappaB-dependent transcription. Second, MAML1 causes degradation of the inhibitor of NF-kappaB (IkappaBalpha). Maml1-deficient mouse embryonic fibroblasts showed impaired tumor necrosis f</description><dates><release>2010-01-01T00:00:00Z</release><publication>2010 May</publication><modification>2025-04-04T11:56:11.543Z</modification><creation>2019-03-27T00:30:30Z</creation></dates><accession>S-EPMC2863211</accession><cross_references><pubmed>20231278</pubmed><doi>10.1074/jbc.m109.078865</doi><doi>10.1074/jbc.M109.078865</doi></cross_references></HashMap>